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ABSTRACT
An understanding of tissue data variability in relation to processing techniques 
during and postsurgery would be desirable when testing surgical specimens for 
clinical diagnostics, drug development, or identification of predictive biomarkers.
Specimens of normal and colorectal cancer (CRC) tissues removed during 
colon and liver resection surgery were obtained at the beginning of surgery and 
postsurgically, tissue was fixed at 10, 20, and 45 minutes. Specimens were analyzed 
from 50 patients with primary CRC and 43 with intrahepatic metastasis of CRC using 
a whole genome gene expression array. Additionally, we focused on the epidermal 
growth factor receptor pathway and quantified proteins and their phosphorylation 
status in relation to tissue processing timepoints.
Gene and protein expression data obtained from colorectal and liver specimens 
were influenced by tissue handling during surgery and by postsurgical processing 
time. To obtain reliable expression data, tissue processing for research and diagnostic 
purposes needs to be highly standardized.
INTRODUCTION
The development of personalized medicine in 
oncology (determining an individual’s disease risk, 
prognosis, and therapeutic options) is fostered by 
high-throughput analysis of molecular biomarkers in 
human cancer biospecimens [1]. Insufficient quality of 
such specimens may lead to spurious results and data 
misinterpretation [2]. Biospecimen quality depends on 
the pre-analytical conditions in which it was acquired 
[3]. Of critical importance is the time interval between 
reducing blood supply and removing the tissue (warm 
ischemia time), and the time interval between removing 
the tissue and preserving its molecular composition (cold 
ischemia time) [4-8]. In addition, patients (cells) are 
exposed to drugs and/or are manipulated in ways that 
may influence expression profiles and pathway activity, 
resulting in inaccurate analytical data. However, there 
are no systematic studies analyzing the impact of pre-
analytical factors.
The present study was conducted to gain a better 
understanding of the effects that warm and cold ischemia 
have on the molecular composition of a tissue specimen. 
Specimens from normal and colorectal cancer 
(CRC) tissue, normal liver and intrahepatic metastases 
of CRC were collected in a highly standardized manner 
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by specially trained staff present during entire surgery, 
both before surgery (presurgery), after hepatic pedicle 
clamping (post-clamping), and at 10, 20, and 45 minutes 
after resection of the tumor (10’, 20’, and 45’ postsurgery, 
respectively). The molecular composition was investigated 
on the RNA, protein, and protein phosphorylation levels 
comparing normal tissue (with a rather homogeneous cell 
composition) with cancer tissue (representing a highly 
heterogeneous tissue with different ratios of malignant and 
[varying subtypes] of non-malignant cells). 
The ultimate goals of this study were to:
i) Use whole genome gene expression analysis to 
provide a list of genes whose expression was unstable 
under warm and cold ischemic conditions and would need 
to be analyzed with caution in research and development 
programs.
ii) Determine variability of epidermal growth 
factor receptor (EGFR)-pathway proteins and their 
phosphorylation status with respect to tissue processing as 
examples of critical clinical biomarkers whose expression 
and activity level inform targeted therapy evaluation in 
cancer.
iii) Identify genes and proteins whose expression 
significantly changes during and after surgery, and 
therefore may serve as biomarkers of tissue quality. 
RESULTS
Patient recruitment
Fifty patients with primary CRC and 43 with 
intrahepatic metastasis of CRC were enrolled in the study. 
From the 50 patients with a primary tumor, 370 formalin-
fixed paraffin-embedded (FFPE) and 780 frozen in liquid 
nitrogen (FF) tissue samples were collected, and from 
the 43 patients with metastasized cancer, 592 FFPE and 
642 FF tissue samples were collected. All samples were 
subjected to morphological quality control (Supplementary 
Figure 1).
Surgery and postsurgical tissue processing 
significantly affects gene expression in normal 
colon, normal liver, and CRC tissue
Ten-minute clamping time of the hepatic artery 
significantly changed the expression of up to 690 (mean 
118) genes in normal liver. The number of affected 
genes increased with surgery time (Figure 1). While 
some genes normalized (vs first biopsy), other genes had 
significant changes in expression level with prolonged 
surgery and postsurgical tissue processing time. The 
number of affected genes in normal liver and normal 
colon was similar (Table 1). In contrast to normal tissue, 
the variability of gene expression in relation to surgery 
and postsurgical processing time was significantly higher 
in cancer tissue. Within 10’ and 45’ postsurgery, up to 
3,087 (mean 830) genes in metastatic liver CRC tumors 
showed ≥2-fold and significant difference in expression. 
In primary CRC tissue, comparison between presurgery 
and 10’ postsurgery biopsies identified up to 3,792 (mean 
1,234) genes and 45’ postsurgery biopsies identified up 
to 4,116 (mean 1,553) genes. Supplementary Tables 1–4 
summarize all genes that showed a significant and ≥2-
fold change in expression during surgery and postsurgical 
processing. 
Identification of potential RNA-based tissue 
quality biomarkers
Hierarchical clustering was used to further evaluate 
gene expression data and to categorize different patient 
groups. Clustering of data from patients who had colon 
surgery (normal and tumor tissue clustering separately) 
resulted in seven different partitions. Most patients (89% 
with normal tissue) fell into the partition (presurgery/10’, 
20’, 45’ postsurgery) meaning that the presurgery 
timepoint separated from the 10’, 20’, and 45’ postsurgery 
timepoints.
Excluding five patients who were regarded 
as outliers, only patients following the partition 
presurgery/10’ 20’ 45’ postsurgery in normal tissue were 
used to compare gene expression intensity levels with 
multiple t-tests between the presurgery and 10’ postsurgery 
timepoints, and presurgery and 45’ postsurgery timepoints. 
In normal colon tissue, 70 probes showed a differential 
expression in both comparisons. Of these, seven probes 
(encoding for five different genes) had a log-fold change 
of ≥2 in both comparisons (Table 2). Expression of another 
five genes showed ≥2 log-fold change in the comparison 
presurgery versus 45’ postsurgery only, while the log-fold 
change was slightly lower in the presurgery versus 10’ 
postsurgery comparison. Genes that were significantly up-
regulated upon resection of normal colon tissue comprised 
transcription factors (EGR1, FOS), signaling molecules 
(CYR61, RGS1, SGK1) of the extracellular matrix, and 
dual specificity phosphatase 1 (DUSP1, a protein that 
dephosphorylates MAPK1). Gene expression for mucosal 
proteins such as dual oxidase 2 (DUOX2, a protein that 
plays a role in antimicrobial defense), solute carrier family 
6 (SLC6A14, a protein mediating amino acid transport), 
and vanin 1 (VNN1, a protein involved in vitamin B5 
recycling), was down-regulated. In colon tumor tissue, 
similar gene expression changes were found for CYR61, 
RGS1, DUSP1, DUOX2, and SLC6A14, although the 
log-fold change was generally lower compared to normal 
tissue (Table 2). 
The same approach was not applicable to normal 
liver tissue because of the low number of affected genes 
and a more diverse change of expression (data not shown). 
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Table 1: Differentially expressed genes in normal colon and liver tissues. Normal colon tissue is shown above the 
line and normal liver tissue shown below the line.  Expression recorded: pre, before hepatic pedicle clamping; post, after 
clamping; 10’, 10 minutes after resection; and 45’, 45 minutes after resection. *p<0.05. 
Probe ID Gene Protein Pre vs 10’ Pre vs 45’
1555827_at CCNL1 Cyclin L1 * *
201324_at
EMP1 Epithelial membrane protein 1
* *
201325_s_at *
202499_s_at SLC2A3 Solute carrier family 2 (facilitated glucose transporter), member 3 * *
202672_s_at ATF3 Activating transcription factor 3 *
202988_s_at RGS1 Regulator of G-protein signaling 1 * *216834_at * *
215034_s_at TM4SF1 Transmembrane 4 L six family member 1 * *
227697_at SOCS3 Suppressor of cytokine signaling 3 * *
232304_at PELI1 Pellino homolog 1 (Drosophila) * *
36711_at MAFF V-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) *
202291_s_at MGP Matrix GLA protein *
209101_at CTGF Connective tissue growth factor *
228335_at CLDN11 Claudin 11 *
202859_x_at IL8 Interleukin 8 *
228528_at LOC100286909 Hypothetical protein LOC100286909 *
Figure 1: The variability of gene expression changes between patients, tissue type, surgery, and tissue processing 
times. The figure shows the number of genes whose expression changed by more than 2-fold according to the tissue source and timing of 
pedicle clamping and postsurgical processing: pre, before hepatic pedicle clamping; post, after clamping; 10’, 10 minutes after resection; 
20’, 20 minutes after resection; and 45’, 45 minutes after resection. Bars represent mean numbers of gene expression changes. 
Oncotarget11020www.impactjournals.com/oncotarget
Identification of housekeeping genes not affected 
by surgery and tissue processing
Gene expression data were sorted according to the 
coefficients of variance (CV). The 10 probe sets with the 
lowest CV across all four timepoints in normal tissue 
are listed in Table 3. While some probe sets encoded 
for insufficiently explored proteins, among those very 
constitutively-expressed genes was eukaryotic translation 
elongation factor 1 alpha 1 (EEF1A1), a widely expressed 
gene with high copy numbers that is known as a potential 
housekeeping gene for gene expression analysis [9]. 
Further well-known housekeeping genes with low CV 
were ribosomal proteins L13 and S18, beta-glucuronidase, 
and beta-actin, while other frequently used housekeeping 
genes, such as beta-2-microglobulin and beta2B-tubulin, 
were not constitutively expressed. 
The same exercise was conducted for gene 
expression in CRC tissue (data not shown). Again, 
EEF1A1 expression showed a very low CV, suggesting 
it may function as a reference gene in both normal and 
neoplastic colorectal tissue. 
Up to 60% of patients showed changes of EGFR-
pathway protein expression 
EGFR and its downstream key signaling proteins 
of the AKT and MAPK pathway were investigated in 
relation to total protein concentration and phosphorylation 
status. Using expression levels of presurgery biopsies as 
a reference, changes (up or down) in protein expression 
of ≥2-fold were documented. In normal liver tissue the 
preclamping tissue biopsy was used as reference. 
Overall, changes in the expression of EGFR-
pathway proteins were lowest in normal liver, higher in 
normal colon, and highest in cancer tissue (Supplementary 
Figure 2). In liver tissue, a change in total protein 
expression was not observed, while in normal colon 
tissue EGFR expression changed ≥2-fold in 10% of 
patients, while expression of the downstream protein 
p70-S6K changed >2-fold in 35% of patients between 
presurgery and 45’ postsurgery. In CRC tissue, expression 
changes in EGFR-related proteins were striking. Between 
presurgery and 10’ postsurgery, EGFR total protein 
expression changed by >2-fold in 20% of all patients 
and in 30% of all patients within a further 35 minutes 
(presurgery/45’ postsurgery). Subsequently, expression of 
downstream proteins, such as p70-S6K, changed >2-fold 
from presurgery to 45’ postsurgery in more than 60% of 
patients. 
While the change in total protein level became 
statistically significant for AKT, MTOR, ERK1/2, 
GSK3B, p70-S6K (Figure 2), and HIF1A (data not 
shown), other proteins (Figure 2) such as EGFR showed 
up- and down-regulation in individual patients and, while 
still showing unstable expression in some patients, it was 
not statistically significant (Supplementary Figure 3). 
Surgery and postsurgical processing strongly 
affects phosphorylation of key signaling molecules 
within the AKT and MAPK pathway 
The phosphorylation status of key signaling proteins 
was significantly affected in most patients and to a larger 
extent in tumor tissue compared with normal tissue. 
We found a chain of phosphorylation events indicating 
activation in some and inactivation in other parts of the 
phosphorylation cascade (data not shown). While these 
changes remain to be evaluated by a more detailed analysis 
of clinical variables, we found statistically significant 
changes in most key regulatory proteins between 
presurgery and 10’ postsurgery samples and additional 
changes for some proteins during the postsurgical cold 
ischemia time. This included AKT, MTOR, ERK1/2, and 
MEK (Figure 2).
In normal colon and liver tissue, total levels of most 
proteins did not differ significantly between timepoints. 
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Table 3: The 10 probe sets (9 genes) with the lowest coefficient of variation (CV) across all four timepoints (presurgery 
and 10, 20, and 45 minutes after resection) in normal colon tissue are shown above the dotted line, and 20 well-known 
housekeeping genes (HKG) with their CV and their rank when sorted for CV are shown below the dotted line.
Probe ID Gene Protein and function Normal tissue Tumor tissue
CV Rank Rank
1558623_at LOC729121 Hypothetical LOC729121 0.0000651769 1 22,547
227472_at DDA1
DET1 and DDB1 associated 1; may be 
involved in ubiquitination and subsequent 
proteosomal degradation
0.0000763301 2 5,095
213477_x_at EEF1A1 Eukaryotic translation elongation factor 1 alpha 1; involved in protein biosynthesis  
0.000120035 3 70
206559_x_at 0.00021194 10 464
203172_at FXR2 Fragile X mental retardation, autosomal homolog 2; RNA-binding protein   0.00012495 4 5,833
202652_at APBB1 Amyloid beta (A4) precursor protein-binding, family B, member 1; transcription coregulator 0.000140598 5 22,323
209394_at ASMTL Acetylserotonin O-methyltransferase-like; unknown function 0.000153558 6 28,176
234891_at DKFZP547L112 Hypothetical protein DKFZp547L112 0.000198356 7 17,884
212986_s_at TLK2 Tousled-like kinase 2; involved in chromatin assembly 0.000208644 8 2,237
223148_at PIGS
Phosphatidylinositol glycan anchor 
biosynthesis, class S; component of the GPI 
transamidase complex
0.000210952 9 24,752
210646_x_at RPL13A Ribosomal protein L13a, HKG 0.000370481 53 752
201049_s_at RPS18 Ribosomal protein S18, HKG 0.000581215 185 2,319
230125_at GUSB Glucuronidase, beta, HKG 0.000939722 647 19,340
AFFX-
HSAC07/
X00351_3_
at
ACTB Actin, beta, HKG 0.001080551 941 7,550
216457_s_at SF3A1 Splicing factor 3a, subunit 1, 120 kDa, HKG 0.001542067 2,363 890
212581_x_at GAPDH Glyceraldehyde-3-phosphate dehydrogenase, HKG 0.001735025 3,208 332
201093_x_at SDHA Succinate dehydrogenase complex, subunit A, flavoprotein (Fp), HKG 0.002533378 8,062 42,630
203135_at TBP TATA box binding protein, HKG 0.003036083 12,044 11,750
203040_s_at HMBS Hydroxymethylbilane synthase, HKG 0.003145361 12,988 6,489
1565446_at HPRT1 Hypoxanthine phosphoribosyltransferase 1, HKG 0.003323065 14,616 23,933
229165_at MRPL12 Mitochondrial ribosomal protein L12, HKG 0.003428532 15,543 12,742
224695_at C2orf29 Chromosome 2 open reading frame 29, HKG 0.00344027 15,651 6,081
211296_x_at UBC Ubiquitin C, HKG 0.003508935 16,259 2,040
235741_at PPIA Peptidylprolyl isomerase A (cyclophilin A), HKG 0.003666547 17,628 33,077
221842_s_at ZNF131 Zinc finger protein 131, HKG 0.003960494 20,273 20,072
227708_at EEF1A1 Eukaryotic translation elongation factor 1 alpha 1, HKG 0.004407467 24,160 24,765
1566191_at SUZ12 Suppressor of zeste 12 homolog (Drosophila), HKG 0.005051028 29,227 49,826
240686_x_at TFRC Transferrin receptor (p90, CD71) , HKG 0.006000472 35,483 30,303
232311_at B2M Beta-2-microglobulin, HKG 0.012872315 49,756 44,528
214023_x_at TUBB2B Tubulin, beta 2B, HKG 0.019826709 52,506 53,778
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Figure 2 (A) Total protein expression (relative units) of p70-S6K, AKT, EGFR, ERK1/2, MTOR, GSK3B, and MEK1/2 in 
normal and tumor colon tissue at four timepoints of tissue collection: pre, before hepatic pedicle clamping; 10’, 10 minutes 
after resection; 20’, 20 minutes after resection; and 45’, 45 minutes after resection.*p<0.05; **p<0.01; ***p<0.001. Box plots 
indicate the 5/95% confidence interval, median, and standard deviation. (B) Percentage of protein phosphorylation of p70-S6K, AKT, 
EGFR, ERK1/2, MTOR, GSK3B, and MEK1/2 in normal and tumor colon tissue at four timepoints of tissue collection: pre, before hepatic 
pedicle clamping; 10’, 10 minutes after resection; 20’, 20 minutes after resection; and 45’, 45 minutes after resection. *p<0.05; **p<0.01; 
***p<0.001. Box plots indicate the 5/95% confidence interval, median, and standard deviation.
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However, there was a statistically significant increase 
at 10’ postsurgery for AKT and MTOR in CRC tissue. 
Protein phosphorylation decreased significantly with 
warm and cold ischemia in normal colon and CRC tumor 
tissue (Figure 2). It is important to note that protein 
phosphorylation showed similar trends for changes in 
selected proteins in both tissue types (normal tissue and 
highly heterogeneous tumor tissue). This implies that these 
regulations occur irrespective of the cell type and, thus, 
could serve as tissue quality marker independent of the 
kind of tissue (normal and tumor).
The above mentioned decline in protein 
phosphorylation was mostly associated with decreased 
stain intensity upon immunohistochemistry, which was 
statistically significant for phosphorylated EGFR, AKT, 
and ERK1/2. Example images of immunohistochemistry 
for the detection of p-AKT in a patient with colon cancer 
in relation to ischemia time are shown in Figure 3. 
HSP27 phosphorylation increases with warm and 
cold ischemia 
HSP27 was evaluated as its expression is known to 
respond to cellular stress [10]. While total HSP27 protein 
levels were similar across all groups, the percentage 
of phosphorylated versus total HSP27 increased over 
time in an almost linear fashion from presurgery to 45’ 
postsurgery in most patients, demonstrating a statistically 
significant difference between presurgery/preclamping 
samples versus those taken after prolonged cold ischemia 
(Supplementary Figure 4). After 45’ postsurgery of cold 
ischemia, the proportion of HSP27 phosphorylation had 
increased 8-fold compared to presurgery levels. In normal 
liver tissue it had increased 2-fold. 
DISCUSSION
Pharmaceutical companies put significant efforts 
into the development of specific pathway inhibitors, and 
new drugs can emerge in high numbers from preclinical 
development programs. Identification of drug targets 
as stratification and predictive biomarkers in patient 
populations has become an important field in drug 
development; indeed, such biomarkers are thought to 
be essential for current and future patient care and an 
important strategy in controlling reimbursement costs in 
cancer care. 
While DNA aberrations such as activating mutations 
in specific genes allow the identification to some extent of 
Figure 3: Representative immunohistochemistry for pAKT on formalin-fixed colon cancer tissue from one patient 
taken at four timepoints: (A) biopsy presurgery; (B) tissue fixed 10 minutes after resection; (C) tissue fixed 20 minutes after 
resection; and (D) tissue fixed 45 minutes after resection.
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drug targets under various circumstances, this approach is 
of limited predictive value. Utilization of protein targets 
and cancer pathway activity as determined by quantifying 
phosphorylation of regulatory proteins can provide a 
much deeper insight into a patient’s individual tumor 
biology. However, a major challenge for the discovery 
and development of predictive drug targets is the need for 
tissue samples that truly represent the reality of a patient’s 
tumor biology. As most tissues are surgical specimens, a 
major concern is the risk of modified expression levels 
because of tissue manipulation during and after surgery. 
Understanding the effects of surgical manipulation 
on cancer biomarkers will be an important part of the 
knowledge base upon which such biomarkers can be fully 
utilized to benefit patients.
Stemming the blood supply rapidly induces hypoxia 
and cellular stress and is thought to affect the molecular 
composition of cells and thus, the analytical data derived 
from these tissues. In addition, during surgery, patients 
(and, naturally, their cells) are exposed to various kinds of 
drugs given by the anesthetist. 
In this study we demonstrate that human tissue 
is highly susceptible to surgical factors and prolonged 
postsurgical ischemia, and standardized handling of 
tissue is an important factor for subsequent analysis. 
Analyzing known stress and ischemia markers such as 
HSP27 [12] and HIF1A [13-14], we found that in normal 
liver tissue, HSP27 phosphorylation was significantly 
increased at 10 minutes after hepatic pedicle clamping 
and further increased throughout post-resection 
ischemia in a time-dependent manner. In normal colon 
tissue, HSP27 phosphorylation increased in an almost 
linear time-dependent manner between 10’ and 45’ 
postsurgery. Hence, HSP27 phosphorylation appears to 
be an interesting marker for pre- and post-resection tissue 
quality. We also found a significant increase in HIF1A 
protein levels 10’ postsurgery of colorectal tumors which, 
however, declined again at later timepoints. Interestingly, 
influence of ischemia on protein phosphorylation has been 
detected independent from tissue type (normal vs cancer) 
and the cellular composition of tumor tissue with respect 
to tumor cell content and non-malignant cell subtypes such 
as stroma cells and inflammatory infiltrates. 
In individual patients the expression of more than 
4,000 genes were altered and up to 60% of patients with 
primary CRC showed more than a 2-fold expression 
change in proteins and their phosphorylation, which is 
in agreement with previous studies demonstrating cold 
ischemia-related alterations in gene and protein expression 
[4, 8]. In general, the impact on the molecular composition 
was more severe in tumor tissue compared to normal 
tissue, likely due to the higher activity of tumor cells 
compared to normal cells. The most striking changes were 
observed during warm ischemia and early cold ischemia 
(10’ postsurgery); gene and protein expression changes 
during prolonged cold ischemia were surprisingly less 
prominent though still significant. Interestingly, up to 
690 (mean 118) genes were already affected in individual 
patients by just clamping the hepatic pedicle for 10 
minutes. 
With regard to gene and protein expression data, we 
observed inter-individual variability across patients. Most 
of these patients, however, appeared to follow a similar 
pattern of gene expression changes. By only using those 
patients for further gene expression analyses, we were able 
to identify significant up-regulation of several transcription 
factors and signaling molecules of the extracellular matrix 
such as cysteine-rich angiogenic inducer 61 (CYR61, 
CCN1), and the regulator of G-protein signaling 1 (RGS1). 
CYR61 is a matrix cell-adhesion molecule. Depending 
on the context, it promotes cell proliferation, survival, 
apoptosis, or angiogenesis by binding to distinct integrins 
and plays an important role in wound repair [15]. RGS1 
attenuates the signaling activity of G-proteins by fostering 
GTP hydrolysis and has various immunomodulatory 
functions [16]. Simultaneously, the expression of several 
genes from colonic enterocytes was down-regulated.
On the protein level, the variability between patients 
was also high. Protein levels and their phosphorylation 
status showed increasing and decreasing levels between 
different patients and timepoints. Variability was 
higher in tumor tissue, probably because of the highly 
heterogeneous cell composition, but also occurred 
in homogeneous normal tissue. This implies that the 
observed changes are to a large extent related to tissue 
processing and not just variability in tumor cell content. 
However, identification of tumor cell-specific events and 
cancer cell biomarker requires analysis of isolated cancer 
cells, which will be performed in follow-up studies.
However, the most consistent molecular change 
during tissue resection and post-surgical ischemia was a 
decrease in protein phosphorylation, observed for AKT, 
MTOR, p70-S6K, GSK3B, and ERK1/2 from colon tissue. 
Dephosphorylation of ERK1/2 is particularly interesting 
with regard to the fact that an up-regulated gene expression 
was found for dual specificity phosphatase 1 (DUSP1, 
MKP1). This protein can dephosphorylate MAPK (ERK) 
in the cell nucleus and thus attenuates MAPK signaling 
[17]. 
Even in our highly standardized tissue processing 
protocol, a comparison between frozen and formalin fixed 
tissue is difficult because the slow formalin penetration 
significantly prolongs the ischemia time (see Methods). 
However, the decline in phosphorylation status observed 
in frozen tissue had an influence on immunohistochemical 
staining for pERK, pAKT, and pEGFR in colon tissue, 
where staining intensity was often lower in postsurgery 
compared to presurgery samples. This has important 
consequences, since immunohistochemistry is frequently 
used to determine activation of signaling pathways 
in individual cancer specimens in order to determine 
personalized treatment options. The pathologist analyzing 
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post-resection specimens needs to be aware of the 
alterations that can be induced by cold ischemia time and 
therefore needs precise information about the conditions 
under which the tissue was procured. Since DUSP1, 
CYR61, and RGS1 gene expression was up-regulated in 
both normal and CRC tissue upon tissue resection, these 
genes may represent interesting candidates for biomarkers 
of post-resection tissue quality. Further evaluations by 
RT-PCR and protein quantification; however, would be 
needed for their characterization and validation as quality 
biomarkers. 
Our study also identified candidate “housekeeping” 
or relatively stable genes, the expression of which was not 
altered by tissue resection and post-surgical cold ischemia. 
In this regard, the EEF1A1 gene appears to be particularly 
interesting. Its CV was very low across all four timepoints, 
both in normal colon tissue and in CRC tissue. EEF1A1 
is known to be constitutively expressed in many tissues 
and under various conditions and has been described as 
a useful housekeeping gene for gene expression analyses 
[18]. Further candidates for reference genes have been 
identified. Interestingly, genes that are frequently used 
as reference genes such as beta2-microglobulin or beta2-
tubulin did not show constitutive expression throughout 
resection and post-surgical ischemia and therefore do not 
appear suitable as housekeeping genes under the described 
conditions.
The data presented herein are largely in agreement 
with a recent report that described fluctuations of protein 
levels and protein phosphorylation in human intestine 
tissue samples as a consequence of different ischemic 
conditions before preservation [8]. The authors reported 
that a general trend towards up- or down-regulation 
of proteins was not evident due to pronounced inter-
individual variability. We were able to demonstrate a 
general trend towards up- and down-regulation of proteins 
and their phosphorylation status due to a higher number of 
samples that were investigated in our study, but confirm 
the occurrence of high inter-individual variability. In 
fact, we identified a majority of patients that responded 
towards tissue resection with a common pattern of gene 
expression changes, while some other patients responded 
in a completely different manner. These inter-individual 
differences require further investigation. 
In summary, our data show a significant difference 
in the molecular composition of tissue specimens collected 
after tumor resection compared to specimens collected via 
colonoscopy before tumor resection. This difference is 
larger than the difference between various post-resection 
times between 10 and 45 minutes. The observed effect 
is either due to warm and cold ischemia, and/or the 
anesthesia/surgical procedure itself, and the manipulation 
of the tissue. The molecular changes induced during 
and after tumor resection are heteromorphic and do not 
occur in all patients. In general, kinase proteins become 
dephosphorylated, which may result in decreased intensity 
of immunohistochemical staining. The ratio between 
phosphorylated and total HSP27 protein has emerged as a 
promising marker for tissue quality, since it demonstrates 
an almost linear increase with prolonged cold ischemia 
time in all three tissue types. 
This study presents an important contribution to 
the understanding of molecular changes that are being 
introduced into tissue samples during the pre-analytical 
phase, i.e. by the tissue collection procedure itself and the 
surgical procedures prior tissue collection. For the first 
time, we provide a full list of genes whose expression is 
altered due to tissue processing and surgical manipulation. 
In addition, our findings suggest that the analysis of 
regulatory pathway proteins and specific growth factor 
receptors, such as EGFR, requires the use of highly 
standardized and rapid tissue processing techniques. Once 
standardized techniques have been validated, analysis of 
the expression of regulatory pathway proteins may be 
valuable as predictive markers of targeted therapies. 
ONLINE METHODS
Patient enrollment
Fifty patients with colorectal cancer (CRC) and 
43 with hepatic metastasis of CRC who were scheduled 
for tumor resection surgery gave informed consent to be 
enrolled in the study. Only patients with a tumor larger 
than 3 cm in diameter were enrolled. Patients who had 
received chemotherapy or radiation therapy <3 weeks 
before surgery were excluded. Specially trained study 
nurses were present during all surgeries. They performed 
tissue processing in the surgical unit and clinical data 
documentation to assure that the same standardized 
operating procedures have been applied to all patients. The 
study was conducted at three sites in Hamburg, Germany, 
and received approval by the competent ethics review 
committee of the medical association Hamburg under 
reference no. PV3342.
Tissue collection before and during surgery
After induction of anesthesia, patients with primary 
CRC underwent a colonoscopy, upon which three biopsies 
were taken from the tumor and three biopsies from the 
adjacent normal tissue (presurgery) (Supplementary Figure 
1). For patients with hepatic metastasis of CRC, four 
pieces of tissue were taken from normal liver parenchyma 
before the start of liver resection, i.e. just before clamping 
of the hepatic artery (presurgery). About 10 minutes 
after hepatic pedicle clamping (post-clamping), another 
four tissue samples were collected from the normal liver 
parenchyma (postsurgery). 
For all patients, 12 tissue samples were each 
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collected from the tumor tissue and the adjacent normal 
tissue after resection of the tumor and adjacent normal 
tissue. These 24 samples were divided into three groups, 
each exposed to a cold ischemia time of 10 minutes (10’), 
20 minutes (20’), and 45 minutes (45’), respectively. 
To minimize variation because of formalin penetration 
time (approximately 1 mm/hour), every tissue sample 
had a similar size of approximately 5 x 5 x 5 mm and an 
approximate weight of 120 mg. Since formalin penetration 
is slow, samples were all fixed for 16 hours. For each 
timepoint and tissue type (normal or tumor), half of the 
tissues were immediately stored in the vapor phase of 
liquid nitrogen, while the other half was immersion fixed 
in 4% buffered formaldehyde (Supplementary Figure 1).
Processing of tissue specimens
All tissue specimens in formaldehyde were 
immersion fixed for 16 to 72 hours. Thereafter, they were 
weighed and placed in 70% ethanol for a maximum of 24 
hours until further processing. Processing was conducted 
with an automated system (Microm tissue processor STP 
420 D Thermo Scientific, Dreieich, Germany) resulting in 
the embedding of tissues in paraffin (Paraplast). 
From each formalin-fixed paraffin-embedded 
(FFPE) and frozen in liquid nitrogen (FF) tissue specimen, 
one section was stained with hematoxylin-eosin and 
evaluated under a light microscope in order to verify the 
presence of tumor and normal tissue, respectively. Tumor 
content was 10–90% in tumor samples and 0% in all 
adjacent normal samples.
After histological quality control, FFPE and FF 
samples were selected for the following molecular 
analyses: i) quantification of total and phosphorylated 
protein by a medium-throughput enzyme-linked 
immunosorbent assay technology (Meso Scale Discovery 
[MSD]); ii) semi-quantitative evaluation of protein 
expression by immunohistochemistry; and iii) gene 
expression profiling on total RNA extracts using an 
Affymetrix whole genome chip (Supplementary Figure 1). 
Quantification of proteins
Forty FF specimens were used. Tissue lysates were 
prepared by cutting and homogenizing a 20 µm slice 
from each FF specimen. The resulting tissue lysate was 
subjected to a bicinchoninic acid protein assay (BCA 
kit; Sigma, Steinheim, Germany) to determine protein 
concentration. Quantification of proteins was conducted 
using 96-well plates with capture antibodies based on the 
assay platform from MSD (Gaithersburg, MD, USA). The 
following assay kits were used: HIF1alpha singleplex, 
HSP27/pHSP27(Ser15) duplex, EGFR/pEGFR(Tyr1173) 
duplex, AKT/pAKT(Ser473) duplex, MTOR/
pMTOR(Ser2448) duplex, p70-S6K/pp70-S6K(Thr421, 
Ser424) duplex, GSK3B/pGSK3B(Ser9) duplex, 
MEK1/2/pMEK1/2(Ser217/221) duplex and ERK1/2/
pERK1/2(Thr202/Tyr204, Thr185/Tyr187) duplex.
Assays were performed using 10 µg of tissue lysate 
according to the manufacturers’ instructions and analyzed 
with the SECTOR Imager platform (MSD). Analyses were 
conducted in triplicate and arithmetic mean values were 
calculated. Mean values of post-surgery samples were 
against presurgery samples from the same patient. The 
percentage of phosphorylation was calculated according to 
the formula: phosphorylation (%) = (DFx phosphorylated 
protein)/(phosphorylated protein + total protein) x 100 
with distribution factor (DF) = 2. If the phosphorylation 
(%) was >100, DF was adjusted. In order to account for 
inter-assay variation, lysates of stimulated human cells 
were produced and employed as positive and negative 
controls.
Immunohistochemistry
5 µm sections from FFPE tissue were mounted on 
glass slides, air dried at 56°C overnight and subjected to 
immunostaining using an automated platform (Ventana 
Discovery XT, Tucson, AZ, USA). The following 
primary antibodies and dilutions were used: pERK1/2 
1:300, pAkt(Ser473) 1:30, pEGFR 1:110, pmTOR 
1:130, pHer3 1:70 (all from Cell Signaling Technology 
Inc., Danvers, MA, USA). After staining, sections were 
treated with ascending ethanol concentrations and xylene 
and were finally covered with Pertex (Medite GmbH, 
Burgdorf, Germany). Sections were examined under a 
light microscope by a pathologist. Tumor cell staining 
was classified as absent, weak, moderate, or strong and 
a staining score was calculated based on the extent of 
staining according to the formula: score = 3 x percentage 
of strongly stained tumor cells + 2 x percentage of 
moderately stained tumor cells + 1 x percentage of weakly 
stained tumor cells. All IHC staining protocols used within 
this study are “fit for purpose” and validated according 
to FDA guidelines, and staining procedures were also 
conducted according to standard operating procedures. 
Therefore, assays are controlled in terms of specificity 
and accuracy.
Gene expression analysis
For gene expression analysis, total RNA was 
extracted in duplicates from every frozen tissue block. 
Briefly, tissues were homogenized and RNA was isolated 
in two steps using phenol chloroform extraction and the 
RNeasy MinElute Cleanup Kit (Qiagen, Hilden, Germany) 
according to the manufacturer’s instructions. RNA 
quality was evaluated based on 18S and 28S ribosomal 
RNA peaks using the Agilent 2100 bioanalyzer (Agilent 
Technologies, Berlin, Germany). Only RNA samples 
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with an RNA integrity number >7 were used for gene 
expression analysis. RNA samples were analyzed in 
replicates using oligonucleotide microarrays (GeneChip 
Human Genome U133 Plus 2.0) based on the Affymetrix 
GeneChip™ technology (Affymetrix Inc., Santa Clara, 
CA, USA).
Statistical analysis
Statistical analysis of protein content measured on 
the MSD platform and statistical analysis of staining scores 
derived from immunohistochemistry was performed with 
the Kruskal-Wallis test and Dunn’s multiple comparisons 
test, using the software system GraphPad Prism Version 
5.0 (GraphPad Software, San Diego, CA, USA). The 
significance level was 0.05. 
Statistical analysis of changes in gene expression 
was preceded by normalization using Affymetrix-Power-
Tools and log2 transformation. Symmetry of the data was 
verified by mean versus average analysis and boxplots. 
As a first approach towards statistical data analysis, 
hierarchical clustering was performed using Spearman 
correlation coefficient as distance measurement. The ward-
linkage method was used to generate dendrograms. Since 
technical replicates were clustered together in almost all 
cases, these replicates were averaged and the average was 
used in further condition clustering, separating samples 
from normal tissue and those that originated from tumors. 
Thereafter, separate data across all four timepoints was 
clustered per individual patient, allowing patients to be 
grouped into distinct partitions.
Separating normal colon tissue from CRC tissue 
samples, only patients from the largest partition group 
were used to compare intensity levels between presurgery 
and 10’ postsurgery timepoints and presurgery and 45’ 
postsurgery timepoints. T-tests were performed and 
p-values were calculated. Probe sets with p>0.001 were 
excluded as were probe sets with <2 log-fold changes 
in intensity. The overlap from both comparisons was 
identified as a list of genes that were particularly 
vulnerable to warm and cold ischemia. A list of all genes 
sorted according to the smallest coefficient of variation 
(CV) was used to identify genes that were apparently not 
vulnerable to warm and cold ischemia.
For detailed comparison between the three different 
cold ischemia time intervals, all samples taken at biopsy 
were excluded from the colorectal data pool. After 
exclusion, cluster dendrograms across the remaining 
three timepoints were generated, allowing patients to be 
grouped into distinct partitions. Patients from the largest 
partition group were used to compare intensity levels 
between presurgery and 10’ postsurgery timepoint and 
presurgery and 45’ postsurgery timepoint. T-tests were 
performed and p-values were calculated. 
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